{"entity":{"type":"insider","cik":"0001313793","url":"/insider/0001313793","json_url":"/insider/0001313793.json","name":"Selisker Rachel R","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":5,"first":"2013-02-11","last":"2014-12-19","span_basis":"filed_date"},"name_variants":[{"name":"Selisker Rachel R","source":"filing","n_filings":5,"first_seen":"2013-02-11","last_seen":"2014-12-19"}],"transactions":[{"id":6991881,"accession":"0001104659-14-087782","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-14-087782","line_url":"/filing/0001104659-14-087782#line-2","is_derivative":false,"issuer_cik":"0000890465","issuer_name":"NPS PHARMACEUTICALS INC","issuer_ticker":"NPSP","issuer_name_source":null,"issuer_url":"/issuer/0000890465","owner_cik":"0001313793","owner_name":"Selisker Rachel R","owner_url":"/insider/0001313793","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3708.0,"shares_display":"3,708","price_per_share":34.5901,"price_display":"34.59","price_state":"stated","total_value":128260.0908,"total_display":"128,260.09","shares_owned_after":7400.0,"shares_owned_after_display":"7,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-17","filed_date":"2014-12-19","scope":"insider"},{"id":6483410,"accession":"0001104659-14-085930","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-14-085930","line_url":"/filing/0001104659-14-085930#line-2","is_derivative":false,"issuer_cik":"0000890465","issuer_name":"NPS PHARMACEUTICALS INC","issuer_ticker":"NPSP","issuer_name_source":null,"issuer_url":"/issuer/0000890465","owner_cik":"0001313793","owner_name":"Selisker Rachel R","owner_url":"/insider/0001313793","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23157.0,"shares_display":"23,157","price_per_share":34.5028,"price_display":"34.50","price_state":"stated","total_value":798981.3396,"total_display":"798,981.34","shares_owned_after":9900.0,"shares_owned_after_display":"9,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-08","filed_date":"2014-12-10","scope":"insider"},{"id":6427341,"accession":"0001104659-14-084333","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-14-084333","line_url":"/filing/0001104659-14-084333#line-2","is_derivative":false,"issuer_cik":"0000890465","issuer_name":"NPS PHARMACEUTICALS INC","issuer_ticker":"NPSP","issuer_name_source":null,"issuer_url":"/issuer/0000890465","owner_cik":"0001313793","owner_name":"Selisker Rachel R","owner_url":"/insider/0001313793","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11635.0,"shares_display":"11,635","price_per_share":34.5009,"price_display":"34.50","price_state":"stated","total_value":401417.9715,"total_display":"401,417.97","shares_owned_after":9900.0,"shares_owned_after_display":"9,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-28","filed_date":"2014-12-02","scope":"insider"},{"id":6818342,"accession":"0001104659-14-080341","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-14-080341","line_url":"/filing/0001104659-14-080341#line-1","is_derivative":false,"issuer_cik":"0000890465","issuer_name":"NPS PHARMACEUTICALS INC","issuer_ticker":"NPSP","issuer_name_source":null,"issuer_url":"/issuer/0000890465","owner_cik":"0001313793","owner_name":"Selisker Rachel R","owner_url":"/insider/0001313793","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15188.0,"shares_display":"15,188","price_per_share":29.5027,"price_display":"29.50","price_state":"stated","total_value":448087.0076,"total_display":"448,087.01","shares_owned_after":9900.0,"shares_owned_after_display":"9,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-11","filed_date":"2014-11-13","scope":"insider"},{"id":4661254,"accession":"0001474064-13-000025","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001474064-13-000025","line_url":"/filing/0001474064-13-000025#line-2","is_derivative":false,"issuer_cik":"0000890465","issuer_name":"NPS PHARMACEUTICALS INC","issuer_ticker":"NPSP","issuer_name_source":null,"issuer_url":"/issuer/0000890465","owner_cik":"0001313793","owner_name":"Selisker Rachel R","owner_url":"/insider/0001313793","role":"Director","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5325.0,"shares_display":"5,325","price_per_share":8.74,"price_display":"8.74","price_state":"stated","total_value":46540.5,"total_display":"46,540.50","shares_owned_after":9900.0,"shares_owned_after_display":"9,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-02-07","filed_date":"2013-02-11","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000890465","name":"NPS PHARMACEUTICALS INC","url":"/issuer/0000890465","role":"Director","n_filings":5,"first_seen":"2013-02-11","last_seen":"2014-12-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001313793","retrieved_at":"2026-08-20T20:58:10+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}